Provectus Biopharmaceuticals, Inc.
Cash Flow Statement
| Line Item | FY2009 |
|---|---|
| Operating Activities | |
| Net Income | $-12.3M |
| Depreciation & Amortization | — |
| Depreciation | $9.4K |
| Amortization | $671.1K |
| Stock-Based Compensation | — |
| Net Cash from Operating Activities | $-8.6M |
| Investing Activities | |
| Capital Expenditures | $5.8K |
| Business Acquisitions | — |
| Net Cash from Investing Activities | $-5.8K |
| Financing Activities | |
| Dividends Paid | — |
| Stock Repurchases | — |
| Net Cash from Financing Activities | $9.0M |
| Net Change in Cash | $441.2K |
| Free Cash Flow | $-8.6M |